{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:55:27Z","timestamp":1770904527105,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK116935"],"award-info":[{"award-number":["K23DK116935"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["K23NR017209"],"award-info":[{"award-number":["K23NR017209"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.metabol.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T01:50:17Z","timestamp":1553046617000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Effects of liraglutide plus phentermine in adults with obesity following 1\u202fyear of treatment by liraglutide alone: A randomized placebo-controlled pilot trial"],"prefix":"10.1016","volume":"96","author":[{"given":"Jena Shaw","family":"Tronieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Wadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert I.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naji","family":"Alamuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana M.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.03.005_bb0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.03.005_bb0010","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2019.03.005_bb0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2013.281361","article-title":"Long-term drug treatment for obesity: a systematic and clinical review","volume":"311","author":"Yanovski","year":"2014","journal-title":"JAMA."},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2019.03.005_bb0020","first-page":"S5","volume":"22","author":"Jensen","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2019.03.005_bb0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2019.03.005_bb0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1037\/0022-006X.71.6.1084","article-title":"Great expectations: \u201cI'm losing 25% of my weight no matter what you say\u201d","volume":"71","author":"Wadden","year":"2003","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.metabol.2019.03.005_bb0035","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1172\/JCI25977","article-title":"Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight","volume":"115","author":"Rosenbaum","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.03.005_bb0040","doi-asserted-by":"crossref","unstructured":"Sumithran P1, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011. 27;365:1597\u2013604.","DOI":"10.1056\/NEJMoa1105816"},{"key":"10.1016\/j.metabol.2019.03.005_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/er.2017-00111","article-title":"Obesity pathogenesis: an Endocrine Society scientific statement","volume":"38","author":"Schwartz","year":"2017","journal-title":"Endocr Rev"},{"issue":"suppl","key":"10.1016\/j.metabol.2019.03.005_bb0050","first-page":"151S","article-title":"Efficacy of lifestyle modification for long-term weight control","volume":"12","author":"Wadden","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/j.metabol.2019.03.005_bb0055","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2019.03.005_bb0060","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/oby.20584","article-title":"Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2019.03.005_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus buproprion on weight loss in overweight and obese adults (COR-I): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial [abstract]","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2019.03.005_bb0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/oby.21811","article-title":"Coadministration of lorcaserin and phentermine for weight management: a 12-week, randomized, pilot safety study","volume":"25","author":"Smith","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2019.03.005_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/oby.22359","article-title":"Intensive behavioral therapy for obesity combined with liraglutide 3.0\u202fmg: a randomized controlled trial","volume":"27","author":"Wadden","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2019.03.005_bb0080","series-title":"Decision memo for intensive behavioral therapy for obesity (CAG-00423N)","author":"Centers for Medicare & Medicaid Services","year":"2011"},{"key":"10.1016\/j.metabol.2019.03.005_bb0085","unstructured":"Adipex-p (phentermine hydrochloride USP) [package insert]. Sellersville, PA: Teva Pharmaceuticals; 2012."},{"key":"10.1016\/j.metabol.2019.03.005_bb0090","unstructured":"Liraglutide (rDNA origin) injection [package insert]. Plainsboro, NJ: Novo Nordisk, Inc.; 2017."},{"key":"10.1016\/j.metabol.2019.03.005_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0195-6663(02)00170-8","article-title":"Agreement between weekly vs. daily assessment of appetite","volume":"40","author":"Womble","year":"2003","journal-title":"Appetite."},{"key":"10.1016\/j.metabol.2019.03.005_bb0100","unstructured":"Tronieri JS, Wadden TA, Berkowitz RI, et al. Effect of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. Int J Obes (Lond) [in press]."},{"key":"10.1016\/j.metabol.2019.03.005_bb0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.metabol.2019.03.005_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short Form Health Survey (SF-36): conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.metabol.2019.03.005_bb0115","series-title":"NY: Columbia University Medical Center","article-title":"Columbia-Suicide Severity Rating Scale (C-SSRS). New York","author":"Posner","year":"2008"},{"key":"10.1016\/j.metabol.2019.03.005_bb0120","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2019.03.005_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/oby.2000.53","article-title":"Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial","volume":"8","author":"Wadden","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.metabol.2019.03.005_bb0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity."},{"key":"10.1016\/j.metabol.2019.03.005_bb0135","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/oby.20584","article-title":"Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity."},{"issue":"10","key":"10.1016\/j.metabol.2019.03.005_bb0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrgastro.2013.119","article-title":"Mechanisms underlying weight loss after bariatric surgery","volume":"10","author":"Miras","year":"2013","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"10.1016\/j.metabol.2019.03.005_bb0145","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s11695-016-2505-5","article-title":"Changes in fasting and prandial gut and adiposity hormones following vertical sleeve gastrectomy or Roux-en-Y-gastric bypass: an 18-month prospective study","volume":"27","author":"Alamuddin","year":"2017","journal-title":"Obes Surg"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519300617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:22:10Z","timestamp":1758428530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519300617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":29,"alternative-id":["S0026049519300617"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.03.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of liraglutide plus phentermine in adults with obesity following 1\u202fyear of treatment by liraglutide alone: A randomized placebo-controlled pilot trial","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}